Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - irradiation
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Synthetic Lethality of IR with ABBV-155 in Glioblastoma (GBM) (UCLA Case No. 2021-232)
UCLA researchers in the Department of Molecular and Medical Pharmacology have discovered that
irradiation
therapy can be combined with an antibody drug conjugate to form a novel therapeutic strategy to treat and extend survival of glioblastoma patients. BACKGROUND: Glioblastoma (GBM) is a fast-growing and aggressive brain tumor. The National Brain...
Published: 8/28/2024
|
Inventor(s):
David Nathanson
Keywords(s):
Antibody-Drug Conjugate
,
Apoptosis
,
Brain cancer
,
Cancer
,
Glioblastoma
,
irradiation
Category(s):
Therapeutics > Oncology
Targeting the Intrinsic Apoptotic Machinery in Glioblastoma Multiforme (GBM) (UCLA Case No. 2020-446)
UCLA researchers in the Department of Molecular and Medical Pharmacology identified the mechanisms of apoptotic resistance in glioblastoma multiforme (GBM) and developed a novel therapy to treat GBM. BACKGROUND: Glioblastoma (GBM) is the most aggressive form of brain tumor. Therapeutic options for GBM are limited and suboptimal. Treatment usually...
Published: 2/16/2024
|
Inventor(s):
David Nathanson
Keywords(s):
anti-apoptotic inhibitor
,
Anti-apoptotic pathway
,
Apoptosis
,
Brain Tumor
,
Glioblastoma
,
irradiation
,
p53
,
temozolomide
Category(s):
Therapeutics > Oncology
Parental A2780 Ovarian Cancer Cell Line and Derivative Cisplatin-resistant and Adriamycin-resistant A2780 Cell Lines
Abstract: Ovarian cancer is one of the most common and lethal types of gynecological malignancies worldwide, accounting for approximately 295,000 new cases and 185,000 deaths annually. The high lethality rate is due to multiple reasons, including recurrence and the resistance of recurrent tumors to chemotherapy. Cell line models are crucial for preclinical...
Published: 4/8/2024
|
Inventor(s):
Stuart Aaronson
,
Nelson Ellmore
Keywords(s):
A2780
,
Aaronson
,
adriamycin
,
CISPLATIN
,
drug resistance
,
IRRADIATION
,
Melphalan
,
OVARIAN CANCER
,
VINBLASTINE
Category(s):
Collaboration Sought > Licensing
,
TherapeuticArea > Oncology
,
Application > Research Materials